Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sacrosidase

EU orphan designation number: EU/3/13/1183   
Active ingredient: Sacrosidase
Indication: Treatment of congenital sucrase-isomaltase deficiency
Sponsor: QOL Therapeutics UK Ltd
25 Southampton Buildings, London, WC2A 1AL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/08/2013 Centralised Orphan - Designation EMA/OD/083/13 (2013)5282 of 05/08/2013
04/03/2014 Other procedure